Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Granules India enters high growing peptide segment, CDMO business by acquiring Senn Chemicals

Ruchika Sharma23 Feb 2025 3:30 PM IST

Hyderabad: Granules India Limited has announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing...

Morepen Labs incorporates new step-down subsidiary in mainland Dubai

Morepen Labs arm to form new subsidary

Ruchika Sharma23 Feb 2025 1:30 PM IST

Haryana: Morepen Laboratories Limited has announced that the Board of Directors of Dr Morepen Limited, a wholly owned subsidiary of the...

GSK Nucala application for COPD accepted for review in China

Ruchika Sharma23 Feb 2025 12:30 PM IST

GSK plc has announced that the China National Medical Products Administration has accepted for review the new drug application for the use of...

Gilead Seladelpar gets Conditional European Marketing Authorization for Primary Biliary Cholangitis

Ruchika Sharma23 Feb 2025 11:30 AM IST

Foster City: Gilead Sciences, Inc. has received conditional marketing authorization from the European Commission (EC) for Seladelpar for the treatment...

Zydus Chairman says Indian pharma players can deliver 100 new drugs by 2047

Ruchika Sharma22 Feb 2025 5:28 PM IST

The Indian pharmaceutical industry has the potential to deliver 100 new drugs for global markets by 2047, driven by enhanced research and development...

Zydus Lifesciences gets NOC from Health Canada for ZDS-Varenicline tablets

Zydus Lifesciences secures USFDA nod for Ibuprofen, Famotidine Tablets for rheumatoid arthritis

Ruchika Sharma22 Feb 2025 4:26 PM IST

Ahmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug Administration...

Abbott India Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy to step down

Ruchika Sharma22 Feb 2025 12:30 PM IST

Mumbai: Abbott India has announced that Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy, has tendered her...

Lupin rolls out Loteprednol Etabonate Ophthalmic Suspension in US

USFDA issues EIR for Lupin Somerset facility

Ruchika Sharma22 Feb 2025 11:30 AM IST

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has issued the...

Sanofi nears selling 50 percent controlling stake in Opella to CD&R

Ruchika Sharma21 Feb 2025 6:16 PM IST

Paris: Sanofi and CD&R have announced that they have signed the share purchase agreement in relation to the sale of a 50 percent controlling...

Kerala: Health Minister Veena George to inaugurate first ever project on collection, disposal of expired medicines

Ruchika Sharma21 Feb 2025 6:15 PM IST

Thiruvananthapuram: In a first in the country, Health Minister Veena George will inaugurate a project on February 22 in Kozhikode for collection of...

USFDA issues 2 observattions for Cipla arm Mahape facility

USFDA issues 2 observations for Cipla arm Mahape facility

Ruchika Sharma21 Feb 2025 1:30 PM IST

Mumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs Administration...

Govt extends deadline for submitting applications under PLI Scheme

Cipla bags USFDA nod for chronic myeloid leukemia drug Nilotinib

Ruchika Sharma21 Feb 2025 11:30 AM IST

Mumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok